Quest to use Matrix-Bio-developed biomarkers for breast cancer test

04/12/2013 | GenomeWeb Daily News (free registration)

Quest Diagnostics has licensed the rights to biomarkers developed by Matrix-Bio in an effort to create a clinical test for recurrent breast cancer. Matrix-Bio Founder and CSO Dan Raftery called the move "a big step toward our goal to make improved and more efficient testing methods for diagnosing many forms of cancer available to physicians and patients."

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC